Cytotoxic effect of As(III) in Caco-2 cells and evaluation of its human intestinal permeability

Toxicology in Vitro

Volumn 20, Issue 5, 2006, Pages 658-663

  Laparra, José Moisés ^a   Vélez, Dinoraz ^a   Barberá, Reyes ^b   Granero, Luis ^b   Polache, Ana ^b   Montoro, Rosa ^a   Farré, Rosaura ^b  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Apparent permeability coefficients; Arsenite; Caco 2 cells; Thiol redox balance; Transport mechanism

Indexed keywords

ARSENIC; GLUTATHIONE; GLUTATHIONE DISULFIDE; THIOL;

ARTICLE; CARCINOMA CELL; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; HUMAN; HUMAN CELL; INTESTINE MUCOSA PERMEABILITY; OXIDATION REDUCTION REACTION; SECRETION; TRANSPORT KINETICS;

ARSENIC; CACO-2 CELLS; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; INTESTINES; MITOCHONDRIA; OXIDATION-REDUCTION; PERMEABILITY;

EID: 33744514514     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2005.12.005     Document Type: Article

References (35)

1. Aduayom I., Campbell P.G.C., Denizeau F., and Jumarie C. Different transport mechanisms for cadmium and mercury in Caco-2 cells: inhibition of Cd uptake by Hg without evidence for reciprocal effects. Toxicology and Applied Pharmacology 189 (2003) 56-67
2. Baker S., and Baker Jr. R.D. Caco-2 cell metabolism of oxygen-derived radicals. Digestives Diseases and Sciences 38 (1993) 2273-2280
3. Benet L.Z., Izumi T., Zhang Y., Silverman J.A., and Wacher V.J. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. Journal of Control Release 62 (1999) 25-31
4. Bernkop-Schnürch A., Kast C.E., and Guggi D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. Journal of Control Release 93 (2003) 95-103
5. Blais A., Lecoceur S., Milhaud G., Tomé D., and Kolf-Clauw M. Cadmium uptake and transepithelial transport in control and long-term exposed Caco-2 cells: the role of metallothionein. Toxicology and Applied Pharmacology 160 (1999) 76-85
6. Bode A.M., and Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Critical Reviews in Oncology Hematology 42 (2002) 5-24
7. Cepinskas G., Kviets P., and Yee T. Omega (3)-lipid peroxides injure Caco-2 cells-relationship to the development of reduced glutathione antioxidant systems. Gastroenterology 107 (1994) 80-86
8. Das D., Chatterjee A., Samanta G., Mandal B., Chowdhury T.R., Samanta G., Chowdhury P.P., Chanda C., Basu G., Lodh D., Nandi S., Chakraborty T., Mandal S., Bhattacharya S.M., and Chakraborti D. Arsenic contamination in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world. Analyst 119 (1994) 168N-170N
9. Díaz O.P., Leyton I., Muñoz O., Núñez N., Devesa V., Súñer M.A., Vélez D., and Montoro R. Contribution of water, bread, and vegetables (raw and cooked) to dietary intake of inorganic arsenic in a rural village of Northern Chile. Journal of Agricultural and Food Chemistry 52 (2004) 1773-1779
10. Ehrhart J., Gluck M., Mieyal J., and Zeevalk G.D. Functional glutaredoxin (thioltransferase) activity in rat brain and liver mitochondria. Parkinsonism and Related Disorders 8 (2002) 395-400
11. Ekmekcioglu C., Strauss-Blasche G., Leibetseder V.J., and Marktl W. Toxicological and biochemical effects of different beverages on human intestinal cells. Food Research International 32 (1999) 421-427
12. Ekmekcioglu C. A physiological approach for preparing and conducting intestinal bioavailability studies using experimental systems. Food Chemistry 76 (2002) 225-230
13. Hanaoka K., Goessler W., Ohno H., Irgolic K.J., and Kaise T. Formation of toxic arsenical in roasted muscles of marine animals. Applied Organometallic Chemistry 15 (2001) 61-66
14. Hissin P.J., and Hilf R. Fluorometric method for determination of oxidized and reduced glutathione in tissues. Analytical Biochemistry 74 (1976) 214-226
15. Huang R.-N., and Lee T.-C. Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium. Toxicology and Applied Pharmacology 136 (1996) 243-249
16. International Agency for Cancer Research (IARC), 1987. IARC Monographs on the evaluation of carcinogenic risks to humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, vols. 1-42, Supplement 7. International Agency for Cancer Research, Lyon.
17. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicology and Applied Pharmacology 172 (2001) 249-261
18. Laparra J.M., Vélez D., Montoro R., Barberá R., and Farré R. Estimation of arsenic bioaccessibility in edible seaweed by an in vitro digestion method. Journal of Agricultural and Food Chemistry 51 (2003) 6080-6085
19. Laparra J.M., Vélez D., Montoro R., Barberá R., and Farré R. Bioaccessibility of inorganic As species in raw and cooked Hizikia fusiforme seaweed. Applied Organometallic Chemistry 18 (2004) 662-669
20. Laparra J.M., Vélez D., Barberá R., Montoro R., and Farré R. An approach to As(III) and As(V) bioavailability studies with Caco-2 cells. Toxicology In Vitro 19 (2005) 1071-1078
21. Lee T.C., Wei M.L., Chang W.J., Ho I.C., Lo J.F., Jan K.Y., and Haung H. Elevation of glutathione levels and glutathione s-transferase activity in arsenic-resistant chinese-hamster ovary cells. In Vitro Cellular & Developmental Biology-Animal 25 (1989) 442-447
22. Lerman S.A., Clarkson W.T., and Gerson R.J. Arsenic uptake and metabolism by liver cells is dependent on arsenic oxidation state. Chemico-Biological Interactions 45 (1983) 401-406
23. Leslie E.M., Haimeur A., and Waalkes M.P. Arsenic transport by the human multidrug resistance protein 1 (MRP/ABCC)-evidence that a triglutathione conjugate is required. Journal of Biological Chemistry 279 (2004) 32700-32708
24. Liu J., Liu Y., Powell D.A., Waalkes M.P., and Klaassen C.D. Multidrug-resistance mdr1a/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues. Toxicology 170 (2002) 55-62
25. Pinto M., Robine-Leon S., Appay M.D., Kedinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., and Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biology of the Cell 47 (1983) 323-330
26. Pourahmad J., O'Brien P.J., Jokar F., and Daraei B. Carcinogenic metal induced sites of reactive oxygen species formation in hepatocytes. Toxicology in Vitro 17 (2003) 803-810
27. Qian Y., Castranova V., and Shi X. New perspectives in arsenic-induced cell signal transduction. Journal of Inorganic Biochemistry 96 (2003) 271-278
28. Ranaldi G., Consalvo R., Sambuy Y., and Scarino M.L. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum free media. Toxicology In Vitro 17 (2003) 761-767
29. Ramírez P., Eastmond D.A., Laclette J.P., and Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutation Research 386 (1997) 291-298
30. Ramírez P., Del Razo L.M., Gutierrez-Ruiz M.C., and Gonsebatt M.E. Arsenite induces DNA-protein crosslinks and cytokeratin expression in the WRL-68 human hepatic cell line. Carcinogenesis 21 (2000) 701-706
31. Rossman T.G. Mechanism of arsenic carcinogenesis: an integrated approach. Mutation Research 533 (2003) 37-65
32. Thomas D.J., Styblo M., and Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicology and Applied Pharmacology 176 (2001) 127-144
33. Van Campen D.R., and Glahn R.P. Micronutrient bioavailability techniques: accuracy, problems and limitations. Field Crops Research 60 (1999) 93-113
34. Vasken Aposhian H., Zakharyan R.A., Avram M.D., Sampayo-Reyes A., and Wollenberg M.L. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxification of the trivalent arsenic species. Toxicology and Applied Pharmacology 198 (2004) 327-335
35. Zornoza T., Cano-Cebrián M.J., Nalda-Molina R., Guerri C., Granero L., and Polache A. Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (Caco-2 cell monolayers) and in vivo models. European Journal of Pharmaceutical Sciences 22 (2004) 347-356